Christoph Correll to Pharmacovigilance
This is a "connection" page, showing publications Christoph Correll has written about Pharmacovigilance.
Connection Strength
0.031
-
Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring. J Clin Psychiatry. 2017 Sep/Oct; 78(8):e933-e939.
Score: 0.031
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.